MindWalk Holdings Corp. Logo

MindWalk Holdings Corp.

A Bio-Native AI company that integrates AI and lab research for drug discovery.

HYFT | US

Overview

Corporate Details

ISIN(s):
CA45257F2008
LEI:
Country:
United States of America
Address:
INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300, 78701 AUSTIN

Description

MindWalk Holdings Corp. is a Bio-Native AI company that focuses on transforming drug discovery and development. The company operates a biointelligence ecosystem that integrates artificial intelligence, multi-omics data, and advanced laboratory research to make complex biology computable and actionable. This unified platform is designed to accelerate the discovery and development of biologics, including therapeutic antibodies, diagnostics, vaccines, and peptide therapeutics, from target identification through to the clinical stage. Its capabilities are powered by proprietary technologies such as the patented HYFT® technology and the LensAI™ platform, which are adaptable to specific targets, modalities, and program priorities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all MindWalk Holdings Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MindWalk Holdings Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MindWalk Holdings Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Elicera Therapeutics AB Logo
Clinical-stage immuno-oncology company developing cell and gene therapies for cancer.
Sweden
ELIC
Elicio Therapeutics, Inc. Logo
Clinical-stage biotech developing lymph node-targeted immunotherapies for cancer.
United States of America
ELTX
E-Novia Logo
A venture studio and consultancy that transforms Physical AI research into products.
Italy
E9IA
Ensysce Biosciences, Inc. Logo
Clinical-stage pharma firm developing abuse-deterrent drugs for severe pain.
United States of America
ENSC
Enveric Biosciences, Inc. Logo
Develops novel small-molecule therapeutics for neuropsychiatric disorders.
United States of America
ENVB
Eone Diagnomics Genome Center Co., Ltd. Logo
A healthcare company specializing in genetic analysis for personalized medicine.
South Korea
245620
Develops hair loss therapies and provides preclinical CRO services.
South Korea
446440
Equillium, Inc. Logo
Clinical-stage biotech developing therapies for autoimmune & inflammatory disorders.
United States of America
EQ
Eurofins-Cerep Logo
Contract research organization for pre-clinical in vitro drug discovery services.
France
ALECR
Evaxion A/S Logo
A clinical-stage TechBio company developing immunotherapies using an AI platform.
United States of America
EVAX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.